« Previous
Next »
Leukemia Research
Volume 33, Issue 5
, Pages 731-734
, May 2009
High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin’s lymphoma
References
- Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood. 1998;92:3152–3162
- Identification of Bach2 as a B-cell-specific partner for small Maf proteins that negatively regulate the immunoglobulin heavy chain gene 3′ enhancer. EMBO J. 1998;17:5734–5743
- Critical elements of the immunoglobulin heavy chain enhancers for deregulated expression of Bcl-2. Cancer Res. 2003;63:6666–6673
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–511
- Prognostic significance of BACH2 expression in diffuse large B-cell lymphoma: a study of the Osaka lymphoma study group. J Clin Oncol. 2005;23:8012–8017
- . A simplified polymerase chain reaction assay for detection of chromosomal translocations in hematologic malignancies. Diagn Mol Pathol. 1997;6:3–9
- . Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method. Methods. 2001;25:402–408
- . Integration of Epstein-Barr virus into chromosome 6q15 of Burkitt lymphoma cell line (Raji) induces loss of BACH2 expression. Am J Pathol. 2004;164:967–974
- B-cell-specific transcription factor BACH2 modifies the cytotoxic effects of anticancer drugs. Blood. 2003;102:3317–3322
PII: S0145-2126(08)00413-X
doi: 10.1016/j.leukres.2008.09.007
« Previous
Next »
Leukemia Research
Volume 33, Issue 5
, Pages 731-734
, May 2009
